Ziprasidone Capsule Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules
Available Strengths: 20 mg, 40 mg, 60 mg, 80 mg
Reference Brands: Zeldox®(EU); Geodon®(US)
Category: Antipsychotropic Drugs
Ziprasidone Capsule is available in Oral Capsules and strengths such as 20 mg, 40 mg, 60 mg, 80 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ziprasidone Capsule is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Ziprasidone Capsule can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Ziprasidone capsules (brand name: Geodon in the U.S., Zeldox in the EU) are FDA-approved in the United States and EMA-authorized in the European Union for the treatment of schizophrenia and bipolar I disorder (acute manic or mixed episodes) in adults. Regulatory compliance requires GMP-certified oral solid dosage manufacturing, bioequivalence data for generics, and long-term safety and efficacy studies. U.S. labeling includes a boxed warning for increased mortality in elderly patients with dementia-related psychosis. EU marketing authorizations mandate Risk Management Plans (RMPs) and continuous pharmacovigilance. For dossier-ready Ziprasidone capsules, visit Pharmatradz.com.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Clorazepate Dipotassium
Strength:
3.75 mg, 7.5 mg, 15 mg, 5 mg, 10 mg, 20 mg
Form: Tablets, Capsules
Reference Brands: Tranxene (USA), Tranxilium(EU)
View DetailsLumateperone
Strength:
10.5 mg, 21 mg, 42 mg
Form: Capsules
Reference Brands: Caplyta (USA)
View DetailsAmoxapine
Strength:
25 mg, 50 mg, 100 mg, 150 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View DetailsAmisulpride
Strength:
5 mg/2 mL, 50 mg, 100 mg, 200 mg
Form: Tablets / injectable solutions
Reference Brands: Barhemsys (USA), Solian (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers